First trimester screening of serum advanced glycation end products levels of pregnant women who have risk factors for gestational diabetes and their obstetric outcomes: a preliminary case-control study

References

• 2018. ACOG practice bulletin no. 190: gestational diabetes mellitus. Obstetrics and Gynecology 131:e49–e64.
   PubMed Web of Science ®Google Scholar
• Akgol S, Budak MS. 2019. Obstetric and neonatal outcomes of pregnancies with mild gestational hyperglycemia diagnosed at gestational diabetes mellitus screening. Gynecology Obstetrics and Reproductive Medicine 25:138–141.
   Google Scholar
• Akgol S, Obut M, Baglı i, Kahveci B, Budak MS. 2019. An evaluation of the effect of a one or two-step gestational diabetes mellitus screening program on obstetric and neonatal outcomes in pregnancies. Gynecology Obstetrics and Reproductive Medicine 25:62–66.
   Google Scholar
• American Diabetes Association. 2017a. 2. Classification and diagnosis of diabetes. Diabetes Care 40:S11–S24.
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. 2017b. 13. Management of diabetes in pregnancy. Diabetes Care 40:S114–S119.
   PubMedGoogle Scholar
• American Diabetes Association. 2021. 14. Management of diabetes in pregnancy: standards of medical care in diabetes-2021. Diabetes Care 44:S200–S210.
   PubMed Web of Science ®Google Scholar
• Arslan E, Gorkem U, Togrul C. 2020. Is there an association between Kisspeptin levels and gestational diabetes mellitus? Gynecology Obstetrics and Reproductive Medicine 26:179–183.
   Google Scholar
• Băbţan AM, Ilea A, Boşca BA, Crişan M, Petrescu NB, Collino M, et al. 2019. Advanced glycation end products as biomarkers in systemic diseases: premises and perspectives of salivary advanced glycation end products. Biomarkers in Medicine 13:479–495.
   PubMed Web of Science ®Google Scholar
• Bohlender JM, Franke S, Stein G, Wolf G. 2005. Advanced glycation end products and the kidney. American Journal of Physiology. Renal Physiology 289:F645–F659.
   PubMed Web of Science ®Google Scholar
• Buhimschi IA, Zhao G, Pettker CM, Bahtiyar MO, Magloire LK, Thung S, et al. 2007. The receptor for advanced glycation end products (RAGE) system in women with intraamniotic infection and inflammation. American Journal of Obstetrics and Gynecology 196:181 e1–13.
   PubMedGoogle Scholar
• Carpenter MW, Coustan DR. 1982. Criteria for screening tests for gestational diabetes. American Journal of Obstetrics and Gynecology 144:768–773.
   PubMed Web of Science ®Google Scholar
• Catalano PM. 2014. Trying to understand gestational diabetes. Diabetic Medicine : A Journal of the British Diabetic Association 31:273–281.
   PubMed Web of Science ®Google Scholar
• Chekir C, Nakatsuka M, Noguchi S, Konishi H, Kamada Y, Sasaki A, et al. 2006. Accumulation of advanced glycation end products in women with preeclampsia: possible involvement of placental oxidative and nitrative stress. Placenta 27:225–233.
   PubMed Web of Science ®Google Scholar
• Chen W, Zhang Y, Yue C, Ye Y, Chen P, Peng W, Wang Y. 2017. Accumulation of advanced glycation end products involved in inflammation and contributing to severe preeclampsia, in maternal blood, umbilical blood and placental tissues. Gynecologic and Obstetric Investigation 82:388–397.
   PubMed Web of Science ®Google Scholar
• Crowther CA, Hiller JE, Moss JR, Mcphee AJ, Jeffries WS, Robinson JS, et al. 2005. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. New England Journal of Medicine 352:2477–2486.
   PubMed Web of Science ®Google Scholar
• Guosheng L, Hongmei S, Chuan N, Haiying L, Xiaopeng Z, Xianqiong L. 2009. The relationship of serum AGE levels in diabetic mothers with adverse fetal outcome. Journal of Perinatology 29:483–488.
   PubMed Web of Science ®Google Scholar
• Harper LM, Jauk V, Longo S, Biggio JR, Szychowski JM, Tita AT. 2020. Early gestational diabetes screening in obese women: a randomized controlled trial. Am J Obstet Gynecol 222:495 e1–495 e8.
   PubMed Web of Science ®Google Scholar
• Kansu-Celik H, Tasci Y, Karakaya BK, Cinar M, Candar T, Caglar GS. 2019. Maternal serum advanced glycation end products level as an early marker for predicting preterm labor/PPROM: a prospective preliminary study. The Journal of Maternal-Fetal & Neonatal Medicine : The Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians 32:2758–2762.
   PubMed Web of Science ®Google Scholar
• Kellow NJ, Savige GS. 2013. Dietary advanced glycation end-product restriction for the attenuation of insulin resistance, oxidative stress and endothelial dysfunction: a systematic review. European Journal of Clinical Nutrition 67:239–248.
   PubMed Web of Science ®Google Scholar
• Lane RH. 2014. Fetal programming, epigenetics, and adult onset disease. Clinics in Perinatology 41:815–831.
   PubMed Web of Science ®Google Scholar
• Li S, Yang H. 2019. Relationship between advanced glycation end products and gestational diabetes mellitus. The Journal of Maternal-Fetal & Neonatal Medicine : The Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians 32:2783–2789.
   PubMed Web of Science ®Google Scholar
• Menon R, Behnia F, Polettini J, Richardson LS. 2020. Novel pathways of inflammation in human fetal membranes associated with preterm birth and preterm pre-labor rupture of the membranes. Seminars in Immunopathology 42:431–450.
   PubMed Web of Science ®Google Scholar
• Mertoglu C, Gunay M, Gungor M, Kulhan M, Kulhan NG. 2019. A study of inflammatory markers in gestational diabetes mellitus. Gynecology Obstetrics & Reproductive Medicine 25:7–11.
   Google Scholar
• Myatt L. 2006. Placental adaptive responses and fetal programming. The Journal of Physiology 572:25–30.
   PubMed Web of Science ®Google Scholar
• Nowotny K, Jung T, Hohn A, Weber D, Grune T. 2015. Advanced glycation end products and oxidative stress in type 2 diabetes mellitus. Biomolecules 5:194–222.
   PubMed Web of Science ®Google Scholar
• Parisi F, Milazzo R, Savasi VM, Cetin I. 2021. Maternal low-grade chronic inflammation and intrauterine programming of health and disease. International Journal of Molecular Sciences 22:1732.
   PubMed Web of Science ®Google Scholar
• Perovic M, Gojnic M, Arsic B, Pantic I, Stefanovic T, Kovacevic G, et al. 2015. Relationship between mid-trimester ultrasound fetal liver length measurements and gestational diabetes mellitus. Journal of Diabetes. 7:497–505.
   PubMed Web of Science ®Google Scholar
• Pertyńska-Marczewska M, Głowacka E, Sobczak M, Cypryk K, Wilczyński J. 2009. Glycation endproducts, soluble receptor for advanced glycation endproducts and cytokines in diabetic and non-diabetic pregnancies. American Journal of Reproductive Immunology (New York, N.Y. : 1989) 61:175–182.
   PubMed Web of Science ®Google Scholar
• Powe CE. 2017. Early pregnancy biochemical predictors of gestational diabetes mellitus. Current Diabetes Reports 17:12.
   PubMed Web of Science ®Google Scholar
• Rajaraman B, Ramadas N, Krishnasamy S, Ravi V, Pathak A, Devasena CS, et al. 2019. Hyperglycaemia cause vascular inflammation through advanced glycation end products/early growth response-1 axis in gestational diabetes mellitus. Molecular and Cellular Biochemistry 456:179–190.
   PubMed Web of Science ®Google Scholar
• Sacks DA, Hadden DR, Maresh M, Deerochanawong C, Dyer AR, Metzger BE, et al. 2012. Frequency of gestational diabetes mellitus at collaborating centers based on IADPSG consensus panel-recommended criteria: the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study. Diabetes Care 35:526–528.
   PubMed Web of Science ®Google Scholar
• Sisay M, Edessa D, Ali T, Mekuria AN, Gebrie A. 2020. The relationship between advanced glycation end products and gestational diabetes: A systematic review and meta-analysis. PLoS One 15:e0240382.
   PubMed Web of Science ®Google Scholar
• Sultana Z, Maiti K, Aitken J, Morris J, Dedman L, Smith R. 2017. Oxidative stress, placental ageing-related pathologies and adverse pregnancy outcomes. American Journal of Reproductive Immunology 77:e12653.
   Web of Science ®Google Scholar
• Tsukahara H, Ohta N, Sato S, Hiraoka M, Shukunami K, Uchiyama M, et al. 2004. Concentrations of pentosidine, an advanced glycation end-product, in umbilical cord blood. Free Radical Research 38:691–695.
   PubMed Web of Science ®Google Scholar
• Ulrich P, Cerami A. 2001. Protein glycation, diabetes, and aging. Recent Progress in Hormone Research 56:1–21.
   PubMedGoogle Scholar
• Uribarri J, Cai W, Sandu O, Peppa M, Goldberg T, Vlassara H. 2005. Diet-derived advanced glycation end products are major contributors to the body’s AGE pool and induce inflammation in healthy subjects. Annals of the New York Academy of Sciences 1043:461–466.
   PubMed Web of Science ®Google Scholar
• Vlassara H, Cai W, Tripp E, Pyzik R, Yee K, Goldberg L, et al. 2016. Oral AGE restriction ameliorates insulin resistance in obese individuals with the metabolic syndrome: a randomised controlled trial. Diabetologia 59:2181–2192.
   PubMed Web of Science ®Google Scholar
• Vlassara H, Uribarri J. 2014. Advanced glycation end products (AGE) and diabetes: cause, effect, or both? Current Diabetes Reports 14:453.
   PubMed Web of Science ®Google Scholar
• Yamagishi S, Nakamura N, Suematsu M, Kaseda K, Matsui T. 2015. Advanced Glycation End Products: A Molecular Target for Vascular Complications in Diabetes. Molecular Medicine (Cambridge, Mass.) 21 Suppl 1:S32–S40.
   PubMed Web of Science ®Google Scholar
• Yan JY, Jiang LL. 2015. Expression of advanced glycation end products in placenta and concentration in maternal and umbilical serum in pre-eclampsia. The Journal of Obstetrics and Gynaecology Research 41:843–849.
   PubMed Web of Science ®Google Scholar